CompletedPhase 4NCT03275415

Intratracheal Budesonide/Surfactant Prevents BPD

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Taipei Medical University
Principal Investigator
Tsu F Yeh, M.D., Ph.D.
Maternal Child Health Research Center, Taipei Medical University
Intervention
budesonide(drug)
Enrollment
310 enrolled
Eligibility
All sexes
Timeline
2019 – 2022

Study locations (1)

Collaborators

Taipei Medical University Hospital · National Taiwan University Hospital · Taipei Veterans General Hospital, Taiwan · Mackay Memorial Hospital · Chang Gung Memorial Hospital · China Medical University Hospital · Seventh Medical Center of PLA General Hospital · Guangzhou Women and Children's Medical Center · Taichung Veterans General Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03275415 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia →

← Back to all trials